Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

September 3, 2022

Study Completion Date

March 3, 2023

Conditions
Non ST Segment Elevation Acute Coronary Syndrome
Interventions
DRUG

Prasugrel 10mg

Once daily 10 mg prasugrel for 12 months preceded by a loading dose of 60 mg prasugrel at least 2 hours prior to percutaneous coronary intervention without concurrent aspirin therapy.

DRUG

Ticagrelor 90mg

Twice daily 90 mg ticagrelor for 12 months preceded by a loading dose of 180 mg ticagrelor at least 2 hours prior to percutaneous coronary intervention without concurrent aspirin therapy.

Trial Locations (1)

1105AZ

Amsterdam UMC, location AMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT04766437 - Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy | Biotech Hunter | Biotech Hunter